{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:42Z","timestamp":1787610102576,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcopenia is an emerging complication of type 2 diabetes mellitus (T2DM) characterized by progressive loss of skeletal muscle mass and function. Diabetic cardiomyopathy (DCM) is a distinct cardiac disease in T2DM patients independent of coronary artery disease and hypertension. Whether sarcopenia independently predicts DCM risk in T2DM patients, and whether shared molecular pathways including systemic inflammation and metabolic dysregulation underlie this association, remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study enrolled 400 T2DM patients admitted to the First Affiliated Hospital of Chongqing Medical University between February 2022 and February 2026. Sarcopenia was diagnosed using AWGS 2019 criteria as the primary framework, with concurrent evaluation against the updated AWGS 2025 criteria. DCM was diagnosed by Doppler echocardiography in T2DM patients with myocardial dysfunction after excluding other cardiac etiologies, per clinically established criteria (2024 ESC DCM position statement); this echocardiographic approach, while standard practice, does not carry the tissue-characterization precision of cardiac MRI. Multivariate logistic regression (three sequentially adjusted models), propensity score matching, and prespecified subgroup analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sarcopenia was identified in 137\/400 patients (34.3%) and DCM in 113\/400 (28.3%). DCM prevalence was significantly higher in sarcopenic versus non-sarcopenic patients (44.5% vs. 19.8%, p &amp;lt; 0.001). After full adjustment, sarcopenia remained independently associated with DCM risk (adjusted OR = 2.70, 95% CI: 1.72\u20134.24, p &amp;lt; 0.001; AUC-ROC = 0.812). The association was consistent across all subgroups (all p-interaction &amp;gt; 0.05). Sarcopenic patients exhibited elevated hs-CRP, NT-proBNP, ferritin, and uric acid, with lower vitamin D levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sarcopenia is independently associated with significantly elevated DCM risk in T2DM patients; the cross-sectional design precludes definitive causal inference and directionality requires prospective longitudinal confirmation. Shared mechanisms\u2014including systemic inflammation, elevated ferritin and uric acid, and potentially common genetic regulatory pathways (hypothesized on the basis of existing literature)\u2014may underlie the muscle\u2013heart dysfunction axis. Routine sarcopenia screening using AWGS 2019 criteria\u2014consistent with the updated AWGS 2025 framework\u2014may facilitate early identification of T2DM patients at elevated DCM risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1892826","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:10:52Z","timestamp":1787609452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between sarcopenia and the risk of diabetic cardiomyopathy in patients with type 2 diabetes mellitus: a single-center retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Laboratory of Research and Translation for Geriatric Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Shapingba Hospital Affiliated to Chongqing University (Shapingba District People\u2019s Hospital of Chongqing)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Practice, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Laboratory of Research and Translation for Geriatric Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Laboratory of Research and Translation for Geriatric Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Laboratory of Research and Translation for Geriatric Diseases, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/diseases11040175","article-title":"Association between sarcopenia and poor glycemic control in older adults with type 2 diabetes mellitus","volume":"11","author":"Alfaro-Alvarado","year":"2023","journal-title":"Diseases"},{"key":"B2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/dom.15372","article-title":"In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: a prospective cohort study from the UK biobank","volume":"26","author":"Boonpor","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/DMSO.S410834","article-title":"The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy","volume":"16","author":"Chen","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the Asian working group for sarcopenia 2025 consensus update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat. Aging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdr2.70064","article-title":"Inflammation, immunity, and cardiovascular diseases","volume":"2","author":"Guo","year":"2026","journal-title":"Med Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e052592","DOI":"10.1136\/bmj-2019-052592","article-title":"Sarcopenia: early prevention or overdiagnosis?","volume":"376","author":"Haase","year":"2022","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41569-019-0323-2","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced cardiac metabolic, structural, and functional abnormality","volume":"17","author":"Jia","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1083722","DOI":"10.3389\/fendo.2023.1083722","article-title":"Alternative skeletal muscle index for sarcopenia diagnosis in elderly T2DM patients: a pilot study","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas 10th edition scientific committee. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Magliano","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"725532","DOI":"10.3389\/fcvm.2021.725532","article-title":"Molecular mechanisms and epigenetic regulation in diabetic cardiomyopathy","volume":"8","author":"Mittal","year":"2021","journal-title":"Front. Cardiovasc Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.3390\/nu13103519","article-title":"Metabolic syndrome and sarcopenia","volume":"13","author":"Nishikawa","year":"2021","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/1753-0407.13203","article-title":"Combined association of skeletal muscle mass and grip strength with cardiovascular diseases in T2DM patients","volume":"13","author":"Park","year":"2021","journal-title":"J. Diabetes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","article-title":"Sarcopenia and chronic complications of type 2 diabetes mellitus","volume":"18","author":"Purnamasari","year":"2022","journal-title":"Rev. Diabet. Stud."},{"key":"B18","doi-asserted-by":"publisher","first-page":"526.e9\u201317","DOI":"10.1016\/j.amjmed.2005.10.049","article-title":"Inflammatory markers and loss of muscle mass (Sarcopenia) and strength","volume":"119","author":"Schaap","year":"2006","journal-title":"Am. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur. Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the heart failure association of the ESC and the ESC working group on myocardial and pericardial diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur. J. Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12902-024-01722-1","article-title":"Risk and determinants of sarcopenia in people with diabetes: a case-control study from Qatar biobank cohort","volume":"24","author":"Shatila","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12877-022-03098-0","article-title":"Longitudinal study on muscle status progression in older multiethnic Asians with T2DM","volume":"22","author":"Tan","year":"2022","journal-title":"BMC Geriatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e13464","DOI":"10.1111\/1753-0407.13464","article-title":"Associations between handgrip strength and skeletal muscle mass with all-cause mortality and cardiovascular mortality in people with type 2 diabetes: a prospective cohort study of the UK Biobank","volume":"16","author":"Wei","year":"2024","journal-title":"J. Diabetes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70774","DOI":"10.1002\/mco2.70774","article-title":"Epigenetic regulation in cardiovascular diseases: mechanisms and therapeutic targets","volume":"7","author":"Zhao","year":"2026","journal-title":"MedComm"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1892826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:10:53Z","timestamp":1787609453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1892826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":24,"alternative-id":["10.3389\/fgene.2026.1892826"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1892826","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1892826"}}